Nancy H Colburn

age ~84

from Boulder, CO

Get Report

Also known as:

Nancy Hall Colburn
Nancy Colburn Gindhart
Nancy Colburn Hall
Nancy H Gindhart
Nancy C Gindhart

Connected to:

Nancy Colburn Phones & Addresses

Boulder, CO
Winter Park, CO
4511 Willow Tree Dr, Middletown, MD 21769 • (301)3716928
4S11 Willow Tree Dr, Middletown, MD 21769 • (301)3716928
Frederick, MD

License Records

Nancy Ann Colburn

License #:

41970 - Expired

Category:

Nursing

Issued Date:

Mar 3, 1986

Effective Date:

Jan 1, 1991

Expiration Date:

Oct 31, 1988

Type:

Registered Nurse

Medicine Doctors

Nancy Colburn

view source

Specialties:

Psychologist

Work:

Metta Health Center
135 Jackson St, Lowell, MA 01852
(978)4411700 (phone), (978)4541681 (fax)

Languages:

English
Korean
Spanish
Vietnamese

Description:

Dr. Colburn works in Lowell, MA and specializes in Psychologist. Dr. Colburn is affiliated with Lowell General Hospital and Lowell General Hospital Saints Campus.

Nancy Theresa Colburn

view source

Specialties:

Anesthesiology

Education:

Medical College of Ohio (1985)

Us Patents

Nuclear Factor Kappa B Pathway Inhibitor Composition And Use Of Same
view source
US Patent:

20110190240, Aug 4, 2011
Filed:

Sep 22, 2009
Appl. No.:

13/120044
Inventors:

Curtis J. Henrich - Rockville MD, US
Moon-Il Kang - Gyeongsangnam-do, KR
Heidi R. Bokesch - Frederick MD, US
Kirk R. Gustafson - Frederick MD, US
Nancy H. Colburn - Middletown MD, US
Matthew R. Young - Ijamsville MD, US
James B. McMahon - Frederick MD, US
Assignee:

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES - Bethesda MD
International Classification:

A61K 31/655
A61P 35/00
A61P 3/10
A61P 35/02
A61P 29/00
A61P 13/08
A61P 1/18
A61P 1/04
A61P 11/06
C12Q 1/02
US Classification:

514150, 435 29
Abstract:

An embodiment of the invention provides a pharmaceutical composition comprising a compound of formula (I)a pharmaceutically acceptable salt, prodrug, hydrate, or solvate thereof. Another embodiment of the invention provides a method of treating or preventing a condition associated with increased expression and/or activity of an NFκB pathway using same compounds. A further embodiment of the invention provides a method of diagnosing a condition in an individual using same compounds.

Dominant Negative Deletion Mutants Of C-Jun And Their Use In The Prevention And Treatment Of Cancer
view source
US Patent:

6699842, Mar 2, 2004
Filed:

Mar 10, 1994
Appl. No.:

08/213433
Inventors:

Nancy H. Colburn - Middletown MD
Zigang Dong - Frederick MD
Powel H. Brown - North Potomac MD
Michael J. Birrer - Potomac MD
Assignee:

The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:

A01N 4304
US Classification:

514 44, 424 932
Abstract:

The inhibition of AP-1 activity by dominant negative deletion mutants of c-jun is disclosed. This inhibition of AP-1 activity is shown to be associated with inhibition of tumor promoter-induced neoplastic transformation. Therefore, the invention relates to the utilization of dominant negative deletion mutants of c-jun which are inhibitory to tumor promotor-induced neoplastic transformation as therapeutic agents in the prevention and treatment of cancer in mammals.